Pain Management

Shorter office visit length increased risk for inappropriate antibiotic prescribing, coprescribing of opioids and benzodiazepines, and potentially harmful prescriptions for seniors.

A statin tops the list of most commonly prescribed Medicare drugs in most states. But in Alabama, it's Vicoodin, and the number of prescriptions written there exceeds the other 49 states.

Is combination pharmacotherapy better for neuropathic pain than monotherapy? A recent systematic review and meta-analysis has answers.

Get up-to-date on the newest guidance for clinicians managing acute, subacute, and chronic pain in adults with this quick quiz.

Patient Care Guideline Toplines summarize newly revised and updated clinical recommendations from professional societies for convenient, at-a-glance review.

Data from a phase 1 study of nondependent recreational opioid users suggests cebranopadol has a lower potential for abuse compared to C-II and C-IV opioids

Large study comparing spinal cord stimulators to conventional medical management found a lack of clinical benefit for most patients and possible harm to some.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

A preliminary assessment from the FDA suggests certain naloxone products may be safely used without a prescription to prevent opioid overdose deaths.

A guideline topline of the CDC's 2022 clinical guidance for prescribing opioids for pain in adults.

The 2022 guidance covers acute, subacute, and chronic pain and replaces the 2016 guidelines.

Gabapentin-involved overdose deaths doubled in Q2 2020 compared to Q1 2019, the CDC reports. What do you know, and maybe not know, about the troubling trend?

A discussion with Lynn Webster, MD, about the importance and future of mobile health technology for chronic pain management.

Benjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.

Benjamin W. Friedman, MD, MS, presents a case of a 27-year-old man with acute pain.

Drs Benjamin W. Friedman, Francesca Beaudoin, Paul Arnstein, and Jeff Gudin discuss new marketed combinations with novel technology when treating acute pain.

Expert pain specialists discuss the role of combination therapy and their experience treating patients with acute pain with a multimodal approach.

Pain experts discuss the issue of substance abuse when selecting therapy for acute pain.

Drs Francesca Beaudoin, Paul Arnstein, and Jeff Gudin discuss treatment approaches to the case of a 40-year-old patient with acute pain.

Benjamin W. Friedman, MD, MS, presents a case of a 40-year-old patient with acute pain.

Is acupuncture effective in reducing pain? Can exercise help patients with fibromyalgia sleep better? New systematic review and meta-analysis provides insight.

Is acupuncture therapy effective for acute perioperative pain and acute pain in the emergency department? A review of the latest evidence, here.

A new study describes growth in prescribing of over-the-counter analgesics and other nonopioid treatments for chronic pain in the 3 years following the CDC guideline.

A new review summarized the current evidence about diagnosis and treatment of lumbar spinal stenosis. What are the key takeaways for primary care?

Dyspareunia significantly impacts quality of life for the women it affects but they may not talk about it. Answer these 10 questions about the condition and you'll be ready to ask.

Study addresses the concern that state opioid prescription laws may lead to some chronic pain patients missing out on critical pain treatment.

A cross-sectional study found that US adults with chronic pain use a variety of pain management techniques, including opioid and nondrug therapies. Key results in this 10-question quiz.

Medical cannabis is already popular with Medicare recipients and many fear insurance coverage will drive up the cost. Find out what else a new survey found.

Opioid refills were reduced by ~40% in the 9 months following an initial prescription for rimegepant among patients with migraine, a new study found.